Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Earth Science TechETST -2.28% Earnings per Share (Diluted) is $0.01 as of Jun. 2026. The stock has 4 warning signs investors should review. Among 787 Drug Manufacturers companies, Earth Science Tech ranks worse than 127064.68% on this metric.
Earth Science Tech's EPS (Basic) for the
three
months ended in Jun. 2026 was $0.00.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2026 was $0.01.
During the past 13 years, Earth Science Tech's highest 3-Year average EPS without NRI Growth Rate was 69.30% per year. The lowest was -43.20% per year. And the median was 35.80% per year.
Earth Science Tech (OTCPK:ETST) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Earth Science Tech Earnings per Share (Diluted) Related Terms
Earth Science Tech Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Earth Science Tech's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Earth Science Tech Earnings per Share (Diluted) Chart
ETST vs IXHL, SCYX, INIS: Earnings per Share (Diluted) Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Earth Science Tech's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Earth Science Tech PE Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Earth Science Tech's PE Ratio distribution charts can be found below:
* The bar in red indicates where Earth Science Tech's PE Ratio falls into.
Earth Science Tech Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Earth Science Tech's Earnings Per Share (Diluted) for the fiscal year that ended in Mar. 2026 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $0.01 mean?
Earth Science Tech (ETST) has a Earnings per Share (Diluted) of $0.01 as of Jun. 2026. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Earth Science Tech and its competitors. According to the industry distribution chart, Earth Science Tech ranks #999999 out of 787 companies in the Drug Manufacturers industry.
Is Earth Science Tech's Earnings per Share (Diluted) too high?
Earth Science Tech's current Earnings per Share (Diluted) is $0.01. The Drug Manufacturers industry median Earnings per Share (Diluted) is 9.70. Earth Science Tech's value of $0.01 is 99.9% below this industry median. Based on the distribution chart, Earth Science Tech ranks #999999 out of 787 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Earth Science Tech's Earnings per Share (Diluted) compare to IXHL and SCYX?
According to the Drug Manufacturers industry distribution chart, Earth Science Tech ranks #999999 out of 787 companies for Earnings per Share (Diluted). This places Earth Science Tech in the lower half of its industry. The industry median Earnings per Share (Diluted) is 9.70. Earth Science Tech's value of $0.01 is 99.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Drug Manufacturers company?
The median Earnings per Share (Diluted) among Drug Manufacturers companies is 9.70, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Earth Science Tech's current Earnings per Share (Diluted) of $0.01 is 99.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Earth Science Tech and its competitors. For the Drug Manufacturers industry, the median Earnings per Share (Diluted) is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Earth Science Tech's current Earnings per Share (Diluted) is $0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Earth Science Tech stock overvalued right now?
Earth Science Tech (ETST) has a current Earnings per Share (Diluted) of $0.01. The current Earnings per Share (Diluted) is $0.01 and 99.9% below the Drug Manufacturers industry median of 9.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Earth Science Tech (ETST), the current Earnings per Share (Diluted) is $0.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Earth Science Tech Inc is a diversified holding company. The company focuses on the health and wellness sector. The Company's principal operating plan is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The Company's healthcare operations are supported by investments in real estate and asset management activities and a consumer products business. The core of the Company's value proposition is the seamless integration of patient care, from consultation to fulfillment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ETST has been successfully added to your 
